Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK

Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK

Context Ellagic acid (EA) is used in traditional medicine to treated hyperlipidaemia. Objective This study examined if AMPK mediates the anti-steatotic effect of ellagic acid (EA) in streptozotocin (STZ)-induced type 1 diabetes mellitus in rats. Materials and methods Adult male Wistar rats (130 ± 10...

Full description

Saved in:
Bibliographic Details
Main Authors: Jozaa Z. ALTamimi (Author), Ghedeir M. Alshammari (Author), Nora A. AlFaris (Author), Reham I. Alagal (Author), Dalal H. Aljabryn (Author), Norah A. Albekairi (Author), Mahmoud Ahmad Alkhateeb (Author), Mohammed Abdo Yahya (Author)
Format: Book
Published: Taylor & Francis Group, 2022-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items